Gracja Topka-Bielecka
Overview
Explore the profile of Gracja Topka-Bielecka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
What, how, and why? - anti-EHEC phages and their application potential in medicine and food industry
Necel A, Dydecka A, Topka-Bielecka G, Wesolowski W, Lewandowska N, Bloch S, et al.
J Appl Genet
. 2024 Nov;
66(1):219-240.
PMID: 39527365
Enterohemorrhagic Escherichia coli (EHEC) are pathogens that, only in the United States, cause more than 250,000 foodborne infections a year. Since antibiotics or other antidiarrheal agents may increase the hemolytic-uremic...
2.
Bloch S, Nejman-Falenczyk B, Licznerska K, Dydecka A, Topka-Bielecka G, Necel A, et al.
J Appl Genet
. 2023 Nov;
65(1):191-211.
PMID: 37968427
Lambdoid bacteriophages are excellent models in studies on molecular aspects of virus-host interactions. However, some of them carry genes encoding toxins which are responsible for virulence of pathogenic strains of...
3.
Kosznik-Kwasnicka K, Podlacha M, Grabowski L, Stasilojc M, Nowak-Zaleska A, Cieminska K, et al.
Front Cell Infect Microbiol
. 2022 Aug;
12:941867.
PMID: 35992162
Phage therapy is a promising alternative treatment of bacterial infections in human and animals. Nevertheless, despite the appearance of many bacterial strains resistant to antibiotics, these drugs still remain important...
4.
Necel A, Bloch S, Topka-Bielecka G, Janiszewska A, Lukasiak A, Nejman-Falenczyk B, et al.
Antibiotics (Basel)
. 2022 Jun;
11(6).
PMID: 35740119
Apart from antibiotic resistance of pathogenic bacteria, the formation of biofilms is a feature that makes bacterial infections especially difficulty to treat. Shiga toxin-producing (STEC) strains are dangerous pathogens, causing...
5.
Necel A, Bloch S, Nejman-Falenczyk B, Dydecka A, Topka-Bielecka G, Wegrzyn A, et al.
Toxins (Basel)
. 2021 Sep;
13(9).
PMID: 34564648
Shiga toxin-producing (STEC) can cause severe infections in humans, leading to serious diseases and dangerous complications, such as hemolytic-uremic syndrome. Although cattle are a major reservoir of STEC, the most...
6.
Topka-Bielecka G, Nejman-Falenczyk B, Bloch S, Dydecka A, Necel A, Wegrzyn A, et al.
Viruses
. 2021 Mar;
13(2).
PMID: 33669643
Phage therapy is one of main alternative option for antibiotic treatment of bacterial infections, particularly in the era of appearance of pathogenic strains revealing resistance to most or even all...
7.
Topka-Bielecka G, Dydecka A, Necel A, Bloch S, Nejman-Falenczyk B, Wegrzyn G, et al.
Antibiotics (Basel)
. 2021 Feb;
10(2).
PMID: 33578658
In addition to specific antibiotic resistance, the formation of bacterial biofilm causes another level of complications in attempts to eradicate pathogenic or harmful bacteria, including difficult penetration of drugs through...
8.
Topka-Bielecka G, Bloch S, Nejman-Falenczyk B, Grabski M, Jurczak-Kurek A, Gorniak M, et al.
Int J Mol Sci
. 2020 Sep;
21(17).
PMID: 32882938
A newly isolated bacteriophage infecting strains has been characterized, including determination of its molecular features. This phage, named vB_EfaS-271, has been classified as a member, according to electron microscopy characterization...